Skip to main content
Log in

Der Tumorsuppressor RECK im Prostatakarzinom

Verminderte RECK-Expression als Indikator für proteolytische Imbalance

  • Leitthema
  • Published:
Der Urologe Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1

Literatur

  1. Jung K, Lein M, Ulbrich N et al. (1998) Quantification of matrix metalloproteinases and tissue inhibitors of metalloproteinase in prostatic tissue: analytical aspects. Prostate 34: 130–136

    Article  PubMed  CAS  Google Scholar 

  2. Lichtinghagen R, Musholt PB, Lein M et al. (2002) Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissue. Eur Urol 42: 398–406

    Article  PubMed  CAS  Google Scholar 

  3. Rabien A, Burkhardt M, Jung M et al. (2007) Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy. Eur Urol 51: 1259–1266

    Article  PubMed  CAS  Google Scholar 

  4. Takahashi C, Sheng Z, Horan TP et al. (1998) Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad Sci USA 95: 13221–13226

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Rabien.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rabien, A., Jung, M., Fritzsche, F. et al. Der Tumorsuppressor RECK im Prostatakarzinom. Urologe 46, 1081–1082 (2007). https://doi.org/10.1007/s00120-007-1434-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-007-1434-2

Navigation